Integrity Orthopaedics Announces Closure of Series B Financing
Summary
MINNEAPOLIS, April 30, 2024-- Integrity Orthopaedics, Inc., a company pioneering next generation solutions for soft tissue repair, has successfully closed on a Series B financing of $20.6 million. "We are grateful for the support of our shareholders, who we view as a strategic asset," stated Thomas Westling, Co-Founder and Chief Executive Officer of Integrity Orthopaedics. My experience using this device has shown that it not only creates a more consistent and efficient repair than other techniques, it also uniquely improves both the strength and the overall healing environment at the time of surgery. Based on the substantial increased strength of the repair and restoration of the entire rotator cuff footprint, surgeons may be more comfortable reducing postoperative sling immobilization for their patients which will lead to their faster and more complete recovery." The PSMB team strives to partner with founders and CEOs of growing, commercial stage businesses that can benefit by leveraging Piper Sandlers knowledge, experience, capital and relationships to build market leading enterprises.